Pittis M G, Ricci V, Guerci V I, Marçais C, Ciana G, Dardis A, Gerin F, Stroppiano M, Vanier M T, Filocamo M, Bembi B
Unità di Malattie Metaboliche, I.R.C.C.S. Burlo Garofolo, Trieste, Italy.
Hum Mutat. 2004 Aug;24(2):186-7. doi: 10.1002/humu.9263.
Niemann Pick disease (NPD) is an autosomal recessive disorder due to the deficit of lysosomal acid sphingomyelinase, which results in intracellular accumulation of sphingomyelin. In the present work we studied 18 patients with NPD type B, including five individuals who presented an intermediate phenotype characterised by different levels of neurological involvement. We identified nine novel mutations in the SMPD1 gene including six single base changes c.2T>G, c.96G>A, c.308T>C, c.674T>C, c.732G>C, c.841G>A (p.M1_W32del, p.W32X, p.L103P, p.L225P, p.W244C, p.A281T) and three frameshift mutations c.100delC, c.565dupC, c.575dupC (p.G34fsX42, p.P189fsX1 and p.P192fsX14). The novel c.2T>G (p.M1_W32del) mutation inactivates the first in-frame translation start site of the SMPD1 gene and in the homozygous status causes NPD type B indicating that in'vivo translation of wild type SMPD1 initiates from the first in-frame ATG. Moreover, the new c.96G>A (p.W32X) introduces a premature stop codon before the second in-frame ATG. As a consequence of either c.2T>G (p.M1_W32del) or c.96G>A (p.W32X), impaired translation from the first in-frame ATG results in a mild NPD-B phenotype instead of the severe phenotype expected for a complete deficiency of the enzyme, suggesting that when the first ATG is not functional, the second initiation codon (ATG33) still produces a fairly functional sphingomyelinase. Analysis of the patients'clinical and molecular data demonstrated that all five patients with the intermediate phenotype carried at least one severe mutation. No association between the onset of pulmonary symptoms and genotype was observed. Finally, the presence of c.96G>A (p.W32X), the most frequent allele among Italian NPD type B population, and c.1799G>C (p.R600P) as compound heterozygotes in association with severe mutations suggested a beneficial effect for both mutations.
尼曼-匹克病(NPD)是一种常染色体隐性疾病,由溶酶体酸性鞘磷脂酶缺乏所致,导致鞘磷脂在细胞内蓄积。在本研究中,我们对18例B型NPD患者进行了研究,其中包括5例表现出中间型表型的个体,其特征为不同程度的神经受累。我们在SMPD1基因中鉴定出9个新突变,包括6个单碱基变化c.2T>G、c.96G>A、c.308T>C、c.674T>C、c.732G>C、c.841G>A(p.M1_W32del、p.W32X、p.L103P、p.L225P、p.W244C、p.A281T)和3个移码突变c.100delC、c.565dupC、c.575dupC(p.G34fsX42、p.P189fsX1和p.P192fsX14)。新的c.2T>G(p.M1_W32del)突变使SMPD1基因的第一个框内翻译起始位点失活,纯合状态下导致B型NPD,这表明野生型SMPD1在体内的翻译从第一个框内ATG起始。此外,新的c.96G>A(p.W32X)在第二个框内ATG之前引入了一个提前终止密码子。由于c.2T>G(p.M1_W32del)或c.96G>A(p.W32X),从第一个框内ATG开始的翻译受损导致轻度NPD-B表型,而非该酶完全缺乏所预期的严重表型,这表明当第一个ATG无功能时,第二个起始密码子(ATG33)仍能产生相当有功能的鞘磷脂酶。对患者临床和分子数据的分析表明,所有5例中间型表型患者至少携带一个严重突变。未观察到肺部症状发作与基因型之间的关联。最后,在意大利B型NPD人群中最常见的等位基因c.96G>A(p.W32X)和c.1799G>C(p.R600P)作为复合杂合子与严重突变同时存在,提示这两种突变具有有益作用。